Cytotoxic effects of 2-methoxyestradiol in the hepatocellular carcinoma cell line HepG2

Pharmacology

Volumn 84, Issue 1, 2009, Pages 9-16

  El Naga, Reem N Abou ^a   El Demerdash, Ebtehal ^a   Youssef, Samar S ^b   Abdel Naim, Ashraf B ^a   El Merzabani, Mahmoud ^b  

^a African Union Organization St Abbassia   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

2 Methoxyestradiol; Angiogenesis; Apoptosis; Hepatocellular carcinoma

Indexed keywords

2 METHOXYESTRADIOL; ANGIOGENIC FACTOR; CASPASE 9; SULFORHODAMINE B; VASCULOTROPIN;

APOPTOSIS; ARTICLE; ASSAY; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN HEPG2; CONTROL GROUP; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 9; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FLOW CYTOMETRY; G2 PHASE; HUMANS; LIVER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 66149089173     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000221062     Document Type: Article

References (34)

1. Sattler M, Quinnan LR, Pride YB, Gramlich JL, Chu SC, Even GC, Kraeft SK, Chen LB, Salgia R: 2-Methoxyestradiol alters cell motility, migration, and adhesion. Blood 2003; 102: 289-296. (Pubitemid 36759667)
2. LaVallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ, Pribluda VS: 2-Methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res 2003; 63: S468-S475. (Pubitemid 36152509)
3. Tinley TL, Leal RM, Randall-Hulbek DA, Cessac JW, Wilkens LR, Rao PN, Mooberry SL: Novel 2-methoxyestradiol analogues with antitumor activity. Cancer Res 2003; 63: 1538-1549. (Pubitemid 36373641)
4. Mabjeesh NJ, Escuin D, La Vallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P: 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003; 3: 363-373. (Pubitemid 38340305)
5. Lin HL, Liu TY, Chau GY, Lui WY, Chi CW: Comparison of 2-methoxyestradiol-induced, doxetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 2000; 89: 983-994.
6. Azab SS, Salama SA, Abdel-Naim AB, Khalifa AE, El-Demerdash E, Al-Hendy A: 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells? Breast Cancer Res Treat 2009; 113: 9-19.
7. Pribluda VS, Green SJ: A good estrogen. Science 1998; 280: 987-988.
8. Chauhan D, Catley L, Hideshima T, Li G, Leblanc R, Gupta D, Sattler M, Richardson P, Schlossman RL, Podar K, Weller E, Munshi N, Anderson KC: 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells. Blood 2002; 100: 2187-2194. (Pubitemid 35001255)
9. James J, Murry DL, Treston AM, Storniolo AM, Sledge GW, Sidor C, Miller KD: Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer. Invest New Drugs 2006; 25: 41-48. (Pubitemid 44657641)
10. Rajkumar SV, Richardson PG, Lacy MQ, Dispenzieri A, Greipp PR, Witzig TE, Schlossman R, Sidor CF, Anderson KC, Gertz MA: Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma. Clin Cancer Res 2007; 13: 6162-6167. (Pubitemid 350075076)
11. Hung H: Treatment modalities of hepatocellular carcinoma. Curr Cancer Drug Targets 2005; 5: 131-138.
12. Wu XZ, Xie GR, Chen D: Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol 2007; 8: 1178-1182. (Pubitemid 47222667)
13. Grude P, Conti F, Mennecier D, Louvel A, Houssin D, Weill B, Calmus Y: MDR1 gene expression in hepatocellular carcinoma and peritumoral liver of patients with and without cirrhosis. Cancer Lett 2002; 186: 107-113. (Pubitemid 35245333)
14. Sun HC, Tang ZY: Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives. J Cancer Res Clin Oncol 2004; 130: 307-319. (Pubitemid 38858340)
15. Lasagna N, Fantappiè O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, Ziche M, Mazzanti R: Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Cancer Res 2006; 66: 2673-2682.
16. Schumacher G, Scheunert S, Rueggeberg A, Bachem MG, Nussler AK, Spinelli A, Mukhopadhyay T, Prastschke J, Neuhaus P: A very low toxic agent induces apoptosis and reduces growth of human hepatocellular carcinoma cells. J Gastroenterol Hepatol 2006; 21: 1207-1212. (Pubitemid 43910016)
17. Ramos S, Alía M, Bravo L, Goya L: Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem 2005; 53: 1271-1280. (Pubitemid 40270427)
18. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 1990; 82: 1107-1112. (Pubitemid 20213250)
19. Li J, Xu L, He K, Guo W, Zheng Y, Xia P, Chen Y: Reversal effects on nomegestrol acetate on multi-drug resistance in adriamycin-resistant MCF-7 breast cancer cell line. Breast Cancer Res 2001; 3: 253-263. (Pubitemid 32633348)
20. Ghavami S, Kerkhoff C, Los M, Hashemi M, Sorg C, Karami-Tehrani F: Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J Leukoc Biol 2004; 76: 169-175. (Pubitemid 38857184)
21. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR: A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acid Res 1994; 2: 5506-5507.
22. Huang GW, Yang LY, Lu WQ: Effects of P13K and p42/p44 MAPK on overexpression of vascular endothelial growth factor in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 809-812. (Pubitemid 38418351)
23. 2/ M arrest by 2-methoxyestradiol in human cervical cancer HeLaS3 cells. Cancer Res 2004; 24: 873-880.
24. Ghosh R, Ott AM, Seetharam D, Slaga TJ, Kumar AP: Cell cycle block and apoptosis induction in a human melanoma cell line following treatment with 2-methoxyestradiol: therapeutic implications? Melanoma Res 2003; 13: 119-127.
25. Kar S, Wang M, Car BI: 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis. Cancer Chemother Pharmacol 2008; 62: 831-840.
26. Chinnaiyan AM, Dixit VM: The cell-death machine. Curr Biol 1996; 6: 555-562.
27. Liu ZJ, Zhu BT: Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J Steroid Biochem Mol Biol 2004; 88: 265-275. (Pubitemid 38553758)
28. Dawling S, Roodi N, Parl FF: Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res 2003; 63: 3127-3132. (Pubitemid 36735863)
29. Lippert TH, Adlercreutz H, Berger MR, Seeger H, Elger W, Mueck AO: Effect of 2- methoxyestradiol on the growth of methylnitroso- urea (MNU)-induced rat mammary carcinoma. J Steroid Biochem Mol Biol 2003; 84: 51-56. (Pubitemid 36324437)
30. LaVallee TM, Zhan XH, Herbstritt CJ, Kough E, Green SJ, Pribluda VS: 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β . Cancer Res 2002; 62: 3691-3697.
31. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W: Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407: 390-395. (Pubitemid 30736017)
32. Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, Waes CV: 2-Methoxyestradiol inhibits hypoxia-inducible factor 1α , tumor growth, and angiogenesis and augments efficacy in head and neck squamous cell carcinoma. Clin Cancer Res 2004; 10: 8665-8673.
33. Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Munshi N, Kharbanda S, Anderson KC: JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J Biol Chem 2003; 278: 17593-17596. (Pubitemid 36799359)
34. Banerjee SN, Sengputa K, Banerjee S, Saxena NK, Banerjee SK: 2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-α : a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells. Neoplasia 2003; 5: 417-426.